Silvr, Thanks for reminding me about Dr. Goldstein's clip on Libgel. He says that Dr. Snabes says if the FDA want 10 years of data, we will give them 10 year of data. You can see he was more excited about it reducing the risk of CV events than treating HSDD. He had to be careful on what he could disclose.
June 6, 2011 BPAX updated the clinical trial sating that it was active but no longer recruiting with 3,656 participants enrolled.
Approximately 5 months after the last participant would have completed 10 years in the study, it looks like a Certification request is submitted.
Market Data 
Markets 
AI
